TABLE 2.
When to consider testing for less common causes of hepatic steatosis and steatohepatitis
Condition | Clinical scenario | Diagnostic test | Treatment |
---|---|---|---|
Hypobetalipoproteinemia | Low LDL, low triglycerides, fat malabsorption | ApoB level, genetic testing (MTTP, PCSK-9) | Low-fat diet, fat-soluble vitamin supplementation |
LAL deficiency | Markedly elevated LDL-C and low HDL-C, elevated triglycerides, xanthelasma, hypersplenism, advanced fibrosis in young age, predominately microvesicular steatosis on liver biopsy | Enzyme assay, genetic testing | LAL replacement |
Nutrient deficiency (eg, carnitine, choline) | Anorexia, short bowel, bypass surgeries | Nutrient levels | Supplementation |
Wilson disease | Younger age, neuropsychiatric symptoms, low alkaline phosphatase, low ceruloplasmin | 24-h urine copper; quantitative copper on liver biopsy | Chelation |
Celiac disease | Iron deficiency, abdominal pain, bloating, vitamin D deficiency, bone loss, diarrhea, dermatitis herpetiformis | Tissue transglutaminase IgA, duodenal biopsy | Gluten-free diet |
Abbreviations: ApoB, apolipoprotein B; HDL-C, high-density lipoprotein cholesterol; IgA, immunoglobulin A; LAL, lysosomal acid lipase; LDL-C, LDL cholesterol.